Abstract | PURPOSE: MATERIALS AND METHODS:
TAX-2'-Et transport was characterized in a human colon carcinoma cell line (Caco-2) and paclitaxel (TAX)-resistant ovarian carcinoma cells (SKOV3/TAX60). Expression of P-gp, multidrug resistance protein (MRP) 2 and Ra-CES was detected by Western blotting. Cytotoxicity against Ra-CES-expressing cells and cellular amount of TAX produced were determined by MTT assay and using HPLC, respectively. RESULTS: Unlike rhodamine123 and TAX, TAX-2'-Et did not exhibit polarized transport in the Caco-2 cells in the absence or presence of verapamil. P-gp levels were expressed much higher in the SKOV3/ TAX60 cells than in the Caco-2 cells. MRP2 protein was not detectable in the SKOV3/TAX60 cells. Uptake by the SKOV3/TAX60 cells was similar in quantity to the amount internalized by P-gp-negative SKOV3 cells. In the SKOV3/TAX60 cells, cellular uptake of TAX-2'-Et was not altered regardless of the absence or presence of verapamil. The cytotoxicity to the untransfected SKOV3 cells induced by TAX-2'-Et was significantly lower than that induced by TAX. In the Ra-CES-expressing SKOV3 line, the EC50 value of TAX (10.6 nM) was approximately four-fold higher than that of TAX-2'-Et (2.5 nM). Transfection of Ra-CES into another TAX-resistant ovarian carcinoma cells (KOC-7c) conferred a high level of TAX-2'-Et cytotoxicity via prodrug activation. The intracellular levels of TAX produced from TAX-2'-Et in the Ra-CES-positive KOC-7c cells significantly increased compared with the levels seen in exposure of the untransfected KOC-7c cells to TAX. CONCLUSIONS:
TAX-2'-Et can circumvent P-gp-associated cellular efflux of TAX. TAX-2'-Et is converted into TAX by the Ra-CES, supporting its potential use as a theoretical GDEPT strategy for cancer cells expressing high levels of P-gp. The TAX-2'-Et prodrug efficiently increased the amount of intracellular TAX, which mediates tumor cell death.
|
Authors | Tadatoshi Tanino, Akihiro Nawa, Eisaku Kondo, Fumitaka Kikkawa, Tohru Daikoku, Tatsuya Tsurumi, Chenhong Luo, Yukihiro Nishiyama, Yuki Takayanagi, Katuhiko Nishimori, Seiji Ichida, Tetsuyuki Wada, Yasuyoshi Miki, Masahiro Iwaki |
Journal | Pharmaceutical research
(Pharm Res)
Vol. 24
Issue 3
Pg. 555-65
(Mar 2007)
ISSN: 0724-8741 [Print] United States |
PMID | 17245652
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ABCC2 protein, human
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antineoplastic Agents, Phytogenic
- Membrane Transport Proteins
- Multidrug Resistance-Associated Protein 2
- Multidrug Resistance-Associated Proteins
- Prodrugs
- Carboxylesterase
- Paclitaxel
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics, metabolism)
- Animals
- Antineoplastic Agents, Phytogenic
(chemistry, pharmacokinetics, pharmacology)
- Biological Transport
- Blotting, Western
- Caco-2 Cells
- Carboxylesterase
(genetics, metabolism)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects, genetics)
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm
- Female
- Humans
- Membrane Transport Proteins
(genetics, metabolism)
- Molecular Structure
- Multidrug Resistance-Associated Protein 2
- Multidrug Resistance-Associated Proteins
(genetics, metabolism)
- Paclitaxel
(chemistry, pharmacokinetics, pharmacology)
- Plasmids
(genetics)
- Prodrugs
(chemistry, pharmacokinetics, pharmacology)
- Rabbits
- Transfection
|